Trial · NCT05049616
Registered outcomes21
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 20 of 21
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Number of Participants With Stage 2 Hypertension | 7-10 after delivery | Stage 2 hypertension at day 7-10 after delivery (defined as SBP ≥ 140 and/or DBP ≥ 90 mmHg) or admission to the hospital for blood pressure control prior to day 10. Primary outcome will be calculated as the average BP reading for day 7-10 after delivery. |
| Secondary | Number of Participants With Severe Postpartum Hypertension | 7-10 after delivery | severe postpartum hypertension (SBP≥160 and/or DBP≥110 mmHg on 2 occasions, 15 minutes apart) |
| Secondary | Number of Participants Who Received Additional Antihypertensive During Admission | 7-10 days postpartum | number of participants who received additional antihypertensive during admission, at 7-10 days postpartum. |
| Secondary | Postpartum Length of Stay | up to 30 days after delivery | time spent in hospital following delivery |
| Secondary | Postpartum Readmission | up to 30 days after delivery | occurrence of returning to hospital for admission postpartum |
| Secondary | Time to Blood Pressure Control | 10 days | The time from delivery to Blood Pressure control (i.e time from delivery to last BP \<150/100). |
| Secondary | Incidence of Persistent Postpartum Hypertension | 6 weeks postpartum | Incidence of persistent postpartum hypertension 6 weeks postpartum (SBP ≥ 140 and/or DBP ≥ 90 mmHg). |
| Secondary | Occurrence of Proteinuria | 7-10 days, and 6 weeks postpartum | Proteinuria is measured by urine protein creatinine ratio |
| Secondary | Presense of Labs Abnormality | 7-10 days, and 6 weeks postpartum | Labs abnormality including hyperkalemia or creatinine increase |
| Secondary | Compliance With Medications | at the time of the 1st postpartum clinic visit, which is about 6 to 37 days after birth | Compliance with medications. The patient will be asked to bring their medication bottle with them and the compliance will be measured by counting pills at each postpartum visit. |
| Secondary | Time to Control Blood Pressure | 3 month-1 year | Blood pressure at 3 month, 6 month, 9 month, 1 year after delivery and need for BP medications. Definition of controlled blood pressure is (SBP \< 140 and/or DBP \< 90 mmHg). This will be assessed by telephone encounter with the patient |
| Secondary | Number of Patients Receiving Primary Care With BP Measurement | 1 year postpartum | Number of patients receiving primary care with BP measurement at 1 year |
| Secondary | Postpartum Complications- Number of Participants With ICU Admission | 10 days postpartum | Need for ICU admission |
| Secondary | Postpartum Complications- Number of Participants With HELLP (Hemolysis, Elevated Liver Enzymes and Low Platelets) Syndrome | 10 days postpartum | Hemolysis, elevated liver enzymes, low platelet count: HELLP |
| Secondary | Postpartum Complications- Number of Participants With Eclampsia | 10 days postpartum | Eclampsia, which is considered a complication of severe preeclampsia, is commonly defined as new onset of grand mal seizure activity and/or unexplained coma during pregnancy or postpartum in a woman with signs or symptoms of preeclampsia. |
| Secondary | Postpartum Complications- Number of Participants With Stroke | 10 days postpartum | Stroke |
| Secondary | Postpartum Complications- Number of Participants With Renal Failure | 10 days postpartum | Renal failure |
| Secondary | Postpartum Complications- Number of Participants With Pulmonary Edema | 10 days postpartum | Pulmonary edema |
| Secondary | Postpartum Complications - Number of Participants With Cardiomyopathy | 10 days postpartum | Cardiomyopathy |
| Secondary | Postpartum Complications- Number of Participants With Maternal Death | 10 days postpartum | Maternal death |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT05049616/registered